Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
EDELMAN JOSEPH | 0001164426 | Jul-29-2019 | 10 percent owner |
PERCEPTIVE ADVISORS LLC | 0001224962 | Jul-29-2019 | 10 percent owner |
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 0001249675 | Jul-29-2019 | 10 percent owner |
BARBARI SHARON SURREY | 0001240499 | Jan-23-2019 | director |
Wiley Matthew T. | 0001759703 | Nov-15-2018 | officer: Chief Commercial Officer |
Bruno Anthony D | 0001374180 | Nov-14-2018 | director |
Harsch Mutya | 0001727809 | Jan-02-2018 | officer: General Counsel and SVP Legal |
STERN STANLEY | 0001098567 | Jan-01-2018 | director |
RIGEL DARRELL S | 0001237422 | Jan-01-2018 | director |
Bright Rex | 0001327501 | Jan-01-2018 | director |
KAZANCHYAN ANNA | 0001369219 | Jan-01-2018 | director |
Howard Alvin D | 0001374174 | Jan-01-2018 | officer: VP Regulatory |
Megiddo Dalia | 0001599618 | Jan-01-2018 | director |
Schwartz Aharon | 0001625184 | Jan-01-2018 | director |
Tamarkin Dov | 0001631962 | Jan-01-2018 | director |
Eini Meir | 0001631964 | Jan-01-2018 | other: Observer to Board of Directors |
Hadar Ilan | 0001727727 | Jan-01-2018 | officer: Country Manager and CFO |
Stuart Iain | 0001727756 | Jan-01-2018 | officer: SVP R&D |
Hazot Yohan | 0001727759 | Jan-01-2018 | officer: VP Pharmaceutical Development |
Schuz David | 0001727761 | Jan-01-2018 | officer: VP IP |
Shirvan Mitchell | 0001727789 | Jan-01-2018 | officer: VP Innovation & Discovery |
Domzalski David | 0001727794 | Jan-01-2018 | officer: CEO |
Elliot Russel | 0001727807 | Jan-01-2018 | officer: VP Drug Development |
Pappacena Bonnie | 0001727808 | Jan-01-2018 | officer: VP Quality |
Hirsch Stanley | 0001727864 | Jan-01-2018 | director, other: Chairman of the Board |
JAY JEFFREY R | 0001239607 | Apr-10-2017 | 10 percent owner |
GREAT POINT PARTNERS LLC | 0001281446 | Apr-10-2017 | 10 percent owner |
KROIN DAVID | 0001397513 | Apr-10-2017 | 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Foamix Pharmaceuticals Ltd.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
EFFECT | Document | Acc-no: 9999999995-20-000600 (33 Act) Size: 1 KB | Mar-20-2020 | 20733455 |
15-12B | Document | Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001104659-20-035792 (34 Act) Size: 10 KB |
Mar-19-2020 | 20728202 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-035413 (33 Act) Size: 36 KB |
Mar-18-2020 | 20725014 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-035410 (33 Act) Size: 36 KB |
Mar-18-2020 | 20725004 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-035409 (33 Act) Size: 36 KB |
Mar-18-2020 | 20724999 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-035407 (33 Act) Size: 36 KB |
Mar-18-2020 | 20724972 |
POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001104659-20-035405 (33 Act) Size: 38 KB |
Mar-18-2020 | 20724951 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-019905 ( Act) Size: 19 KB |
Mar-18-2020 | |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001178913-20-000792 (34 Act) Size: 8710 KB |
Mar-12-2020 | 20707144 |
8-K | Document | Current report filing Acc-no: 0001178913-20-000788 (34 Act) Size: 289 KB |
Mar-12-2020 | 20707131 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018204 ( Act) Size: 14 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018202 ( Act) Size: 21 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018199 ( Act) Size: 18 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018198 ( Act) Size: 14 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018197 ( Act) Size: 18 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018196 ( Act) Size: 16 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018195 ( Act) Size: 32 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018194 ( Act) Size: 28 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018193 ( Act) Size: 8 KB |
Mar-11-2020 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-20-018192 ( Act) Size: 17 KB |
Mar-11-2020 |
Recent 20 filings. View all Foamix Pharmaceuticals Ltd. filings
Very good communication and delivery made within the timeframe I was advised of
Thanks I look forward to using the product to improve my skin tone
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by